72 related articles for article (PubMed ID: 7845013)
21. Inhibition of v-Abl transformation by p53 and p19ARF.
Cong F; Zou X; Hinrichs K; Calame K; Goff SP
Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
[TBL] [Abstract][Full Text] [Related]
22. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.
Whitlock CA; Witte ON
J Virol; 1981 Nov; 40(2):577-84. PubMed ID: 6275106
[TBL] [Abstract][Full Text] [Related]
23. Abelson virus potentiates long-term growth of mature B lymphocytes.
Serunian LA; Rosenberg N
Mol Cell Biol; 1986 Jan; 6(1):183-94. PubMed ID: 3023822
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of temperature-sensitive mutants of Abelson murine leukaemia virus that exhibit dissociation among morphological transformation, soft agar colony-forming ability and tyrosine kinase activity.
Oka Y; Sugiyama H; Tsukada S; Shimizu Y; Inoue H; Hakura A; Kishimoto S
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2527-32. PubMed ID: 2550581
[TBL] [Abstract][Full Text] [Related]
25. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
[TBL] [Abstract][Full Text] [Related]
26. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
27. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
[TBL] [Abstract][Full Text] [Related]
28. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
Engelman A; Rosenberg N
J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
[TBL] [Abstract][Full Text] [Related]
29. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.
Rotter V; Witte ON; Coffman R; Baltimore D
J Virol; 1980 Nov; 36(2):547-55. PubMed ID: 6159484
[TBL] [Abstract][Full Text] [Related]
30. Expression of abl and other oncogenes is independent of metastatic potential in Abelson virus-transformed malignant murine large cell lymphoma.
Rotter V; Wolf D; Blick M; Nicolson GL
Clin Exp Metastasis; 1985; 3(2):77-86. PubMed ID: 4042463
[TBL] [Abstract][Full Text] [Related]
31. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.
Young JC; Gishizky ML; Witte ON
Mol Cell Biol; 1991 Feb; 11(2):854-63. PubMed ID: 1990288
[TBL] [Abstract][Full Text] [Related]
32. NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.
Nakamura Y; Grumont RJ; Gerondakis S
Mol Cell Biol; 2002 Aug; 22(15):5563-74. PubMed ID: 12101248
[TBL] [Abstract][Full Text] [Related]
33. Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene.
Chung SW; Wong PM; Durkin H; Wu YS; Petersen J
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1585-9. PubMed ID: 1996361
[TBL] [Abstract][Full Text] [Related]
34. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
Jacobsen EA; Ananieva O; Brown ML; Chang Y
J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
[TBL] [Abstract][Full Text] [Related]
35. Transformation-associated proteins in murine B-cell lymphomas that are distinct from Abelson virus gene products.
Pillemer E; Whitlock C; Weissman IL
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4434-8. PubMed ID: 6611551
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.
Renshaw MW; Kipreos ET; Albrecht MR; Wang JY
EMBO J; 1992 Nov; 11(11):3941-51. PubMed ID: 1396587
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus.
Noronha EJ; Sterling KH; Calame KL
J Biol Chem; 2003 Dec; 278(51):50915-22. PubMed ID: 14559912
[TBL] [Abstract][Full Text] [Related]
38. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
Thome KC; Radfar A; Rosenberg N
J Virol; 1997 Nov; 71(11):8149-56. PubMed ID: 9343165
[TBL] [Abstract][Full Text] [Related]
39. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
Jackson P; Baltimore D
EMBO J; 1989 Feb; 8(2):449-56. PubMed ID: 2542016
[TBL] [Abstract][Full Text] [Related]
40. Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus-infected hemopoietic stem cells.
Han XD; Wong PM; Chung SW
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10129-33. PubMed ID: 1682923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
